ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Aptevo Therapeutics Inc

Aptevo Therapeutics Inc (APVO)

4.69
0.63
(15.52%)
Closed March 29 04:00PM
4.5719
-0.1181
(-2.52%)
After Hours: 07:58PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.5719
Bid
4.56
Ask
4.69
Volume
304,555
3.95 Day's Range 4.9979
3.81 52 Week Range 92.6156
Market Cap
Previous Close
4.06
Open
4.05
Last Trade Time
Financial Volume
$ 1,320,602
VWAP
4.3362
Average Volume (3m)
407,996
Shares Outstanding
533,464
Dividend Yield
-
PE Ratio
0.31
Earnings Per Share (EPS)
15.05
Revenue
3.11M
Net Profit
8.03M

About Aptevo Therapeutics Inc

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $4.06. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 3.81 to $ 92.6156.

Aptevo Therapeutics currently has 533,464 shares outstanding. The market capitalization of Aptevo Therapeutics is $2.50 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of 0.31.

APVO Latest News

Form 8-K - Current report

0001671584false00016715842024-03-072024-03-07   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

Form 8-K - Current report

--12-310001671584false00016715842024-03-052024-03-05   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

FYfalse0001671584http://fasb.org/us-gaap/2023#RoyaltyMemberhttp://fasb.org/us-gaap/2023#RoyaltyMemberhttp://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMemberhttp://fasb.org/u...

Form 8-K - Current report

0001671584false00016715842024-03-052024-03-05   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

Form 8-K - Current report

0001671584false00016715842024-02-052024-02-05   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form DEFR14A - Revised definitive proxy soliciting materials

mscho UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934(Amendment No...

Form DEFR14A - Revised definitive proxy soliciting materials

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4581-9.107355864815.035.043.81642254.30819433CS
4-2.2569-33.0497305536.828810.83.815184836.28287993CS
12-3.0577-40.07680612357.629610.83.814079966.58006051CS
26-9.3541-67.170041648713.92621.563.814952669.81423563CS
52-76.3881-94.352890316280.9692.61563.8134091417.97896802CS
156-1293.8681-99.6478928561298.441397.443.81515697443.76914364CS
260-33.7961-88.084080483738.36826403.81556859428.39192409CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

APVO Discussion

View Posts
stressfreeliving stressfreeliving 3 weeks ago
Sue for a run again this week.
πŸ‘οΈ0
Renee Renee 3 weeks ago
APVO: effective March 6,2024 a one for 44 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 months ago
What news would turn this turd into gold? It's complete junk at this point and I would almost guarantee the RS will be at 44 to 1.

Went from a promising company when I bought in to nothing but junk.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 2 months ago
Just traded in six figures at .150001, does a hedge fund have inside information on news coming?
$APVO
πŸ‘οΈ0
ErnieBilco ErnieBilco 3 months ago
Another turd who can't do actual work to increase the value so let's just do a RS so it looks better to those who haven't dealt with this crapper before. VOTE NO ACROSS THE BOARD IF YOU GET A BALLOT.
πŸ‘οΈ0
willlbone willlbone 5 months ago
Bid 10 cents.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 5 months ago
It’s a mystery to me why we’re not trading at ten times our current level.
$APVO!!
πŸ‘οΈ0
knrorrel knrorrel 6 months ago
still red today - hope green still today
πŸ‘οΈ0
knrorrel knrorrel 6 months ago
APVO SHOULD RISING - YESTERDAY ALREADY $0.49
imho
πŸ‘οΈ0
knrorrel knrorrel 6 months ago
...then it's time to start a huge recovery today.
imho


πŸ‘οΈ0
knrorrel knrorrel 6 months ago
very nice , thx
πŸ‘οΈ0
knrorrel knrorrel 6 months ago
TIME TO BOUNCING , LET'S GOOOOO
imho


πŸ‘οΈ0
BoscoLives21 BoscoLives21 6 months ago
Alliance Global Partners initiated coverage on Aptevo on October 9th, 2023 at $4.75/ share.
πŸ‘οΈ0
jchords jchords 6 months ago
Quick spike in price.. keeping my eye on this
👍️ 1
BoscoLives21 BoscoLives21 6 months ago
Thanks for the umpteenth update! Company has compounds proven efficacious vs. cancer/leukemia, that’s why it spiked to $70 a couple of years ago. If APVO runs in the near future, remember the warrants/ APVTW…
$APVO
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
APVO new 52 week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
It really does need some good news but I've been nibbling at these cheap shares, I have some healthy positions in the warrants which should also skyrocket on upward moves of the commons

Poco a poco ( Little by little)
πŸ‘οΈ0
BoscoLives21 BoscoLives21 7 months ago
I added as well. Need news!!
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
I added in a few accounts as it dropped so news and parabolic would be fantastic
πŸ‘οΈ0
BoscoLives21 BoscoLives21 7 months ago
It’s going up! News could send this parabolic.
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
What the hell is going on with APVO? Seems to be a bottomless pit.
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
APVO new 52 week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
Dang, they are still beatin this thing down like a cigarette thief in a convenience store by an employee with a beatin stick.
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
APVO new 52=week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
It appears the offering was priced fairly, did not drop as far as I expected.

Added in all accounts
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
Great place to add on the offering mayhem
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
I'm up 40% on my few days of owning APVO - Hoping to hold til it gains me 300% or better.

I have a bunch of bait in the water for the warrants - I really want to add to what I gots.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 8 months ago
I scarfed those .015s a while back after wildly overpaying close to $2. Might try a bid at .015..
$APVO// $APVTW
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
I was shocked that it filled, I usually bid too low to catch these things.

Still trying to lowball the warrants but those are harder to catch where I'm fishin my bait.
👍️ 1
BoscoLives21 BoscoLives21 8 months ago
Great scoop!
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
WOW caught some .782s this morning.
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
Think I'll toss my NFLX gains from today into a split between commons and more warrants. I've already banked huge gains on the warrants way way back, like years ago I think.
👍️ 1
BoscoLives21 BoscoLives21 8 months ago
Exactly, like today, home run news and it tanks. Why? Clearly being accumulated by deep pockets, because they know the science is tight. APTVW warrants are the high risk/ monster return play..
JMHO
$APVO/$APVTW
πŸ‘οΈ0
pinkslipjunkie pinkslipjunkie 1 year ago
It never does for those that hold....
Makes no sense
πŸ‘οΈ0
ErnieBilco ErnieBilco 1 year ago
Almost a 1000 times normal volume and it's given up almost all its gains, is the stock broken or just a piece of crapola?

The news certainly sounded very good so why has it tanked off its high this morning?

Makes no sense
πŸ‘οΈ0
ErnieBilco ErnieBilco 1 year ago
On December 12, 2022, Aptevo Therapeutics Inc. (β€œAptevo” or the β€œCompany”) announced that APVO436, in combination with venetoclax and azacytidine,
achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients. The data, which was presented in a poster session at the 64th American
Society of Hematology Annual Meeting and Exposition in New Orleans, also showed that APVO436, when given in combination with this standard-of-care
regimen, was observed to be generally safe and well tolerated.
Aptevo plans to initiate a Phase 2 trial in the second half of 2023 to further evaluate APVO436 in combination with venetoclax and azacitidine among frontline
and relapsed/refractory AML patients who are venetoclax treatment naïve.
πŸ‘οΈ0
ErnieBilco ErnieBilco 1 year ago
Strong move on the commons this morning let's see if that translates into a strong move on the warrants.
πŸ‘οΈ0
subslover subslover 1 year ago
Could pop today
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Looking for some positive moves with today's news.
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Run Run and don't look back just run harder and harder.
πŸ‘οΈ0
buxmaker buxmaker 2 years ago
APVO looking good today, up 25% on heavy volume. Two complete remissions. Bring back that $50 buyout offer!
πŸ‘οΈ0
buxmaker buxmaker 2 years ago
Thanks 136. APVO's stock has gone straight down for over a year. Any near term catalysts that might turn things around? Any FDA decisions or trial results due soon?
πŸ‘οΈ0
136 136 2 years ago
Yeah it was something about a disagreement regarding an NDA

Also, the warrants are super cheap because the exercise price is $18.20

If APVO moves up significantly toward that… expect the warrants to start moving

I own a good chunk of this stock, so hopefully that happens
πŸ‘οΈ0
buxmaker buxmaker 2 years ago
APVO really turned down a $50 offer? Unreal. Does anyone see value in the warrants? They are trading at .10, near an all time low. If another buyout or some solid news hits, they could be an easy 10 to 20x from here.
πŸ‘οΈ0
pinkslipjunkie pinkslipjunkie 2 years ago
Because he wants it too.
πŸ‘οΈ0
PARker1703 PARker1703 2 years ago
Why and when? Tia
πŸ‘οΈ0
halbroke1 halbroke1 2 years ago
APVO $$$$ EXPLODING BACK TO $20.00+..
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock